Genetic testing is the study of the cells and tissues contained in the gene to get a better understanding of genetic disorders such as like cancer etc. New genetic testing technologies, together with increasing efficiency and accuracy are providing lucrative growth opportunities for the genetic testing market. One such company that is hoping to capitalize on this growth is Invitae (NVTA).
Invitae provides genetic testing services for a wide variety of uses such as inherited disease diagnosis, family planning and proactive health screening (think blood test but genes or something similar to 23andme).